Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Identifying and Treating Depression in the Orthopaedic Trauma Population
NCT05976347Phase 4Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine, duloxetine in major depressive disorder (MDD), sponsored by Wake Forest University Health Sciences. Started Jun 2025; status: recruiting.
02
Drugs
fluoxetineduloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05976347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976347.